The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo (MUTTII)
Sponsor: Aravind Eye Hospitals, India
This PHASE3 trial investigates Corneal Ulcer and Eye Infections, Fungal and is currently completed. Aravind Eye Hospitals, India leads this study, which shows 11 recorded versions since 2010 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Mar 2019 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 6 earlier versions
-
Feb 2019 — Mar 2019 [monthly]
Completed PHASE3
-
Jan 2019 — Feb 2019 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2019 [monthly]
Completed PHASE3
-
Jul 2017 — Jun 2018 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Feb 2017 — Jul 2017 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
May 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aravind Eye Hospitals, India
- Bharatpur Eye Hospital
- Dartmouth-Hitchcock Medical Center
- Lumbini Eye Institute and Research Centre
- National Eye Institute (NEI)
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .